Golden Walk as Measure of Gait Rehabilitation in Parkinson's Disease
Trial
N/A
Unknown
Jan. 21, 2021
Influence of Emotions on Decision-making in Parkinson's Disease
Trial
N/A
Completed
Jan. 18, 2021
DBS and SCS Therapy Improve Motor Function in Multiple System Atrophy With Predominant Parkinsonism
Trial
N/A
Unknown
Jan. 13, 2021
Navigated Repetitive Transcranial Magnetic Stimulation for Parkinson's Disease With Depression or Cognitive Impairment
Trial
N/A
Unknown
Jan. 12, 2021
State-dependent Pathophysiological Oscillations in Parkinson's Disease and Treatment With Deep Brain Stimulation (DBS)
Trial
Phase 1
Completed
Jan. 12, 2021
Efficacy of Proprioceptive Focal Stimulation (EQUISTASI) on Gait Parameters in Parkinson. Italian Multicentric Study
Trial
N/A
Completed
Jan. 11, 2021
rTMS in Facilitation of Working Memory in PD
Trial
N/A
Unknown
Jan. 7, 2021
Asymmetric Subthalamic Deep Brain Stimulation for Axial Motor Dysfunction in Parkinson's Disease
Trial
N/A
Completed
Jan. 4, 2021
Research on the Effect and Mechanism of Aerobic Exercise on PD
Trial
N/A
Unknown
Jan. 4, 2021
Imaging Blood Brain Imaging Dysfunction in Parkinson's Disease
Trial
N/A
Completed
Dec. 30, 2020
Relative Bioavailability and Bioequivalence of Opicapone
Trial
Phase 1
Completed
Dec. 30, 2020
The Stanford Parkinson's Disease Plasma Study
Trial
Phase 1
Completed
Dec. 29, 2020
Effects of Hyperthermic Baths on Motor Symptoms of Parkinson's Disease
Trial
N/A
Completed
Dec. 28, 2020
Establishment of Clinical Basis for Hematopoietic Growth Factors Therapy in Brain Injury
Trial
Phase 1
Unknown
Dec. 27, 2020
Asymmetric DBS for PD : A Multicenter, Prospective, Single Arm, Open Label Study
Trial
N/A
Not yet recruiting
Dec. 23, 2020
Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Trial
Phase 2
Completed
Dec. 23, 2020
Spinal Cord Stimulation Therapy for Freezing of Gait in Parkinson's Syndrome Patients
Trial
N/A
Unknown
Dec. 23, 2020
Shoulder Disorders in Patients With Parkinson's Disease
Trial
N/A
Completed
Dec. 22, 2020
Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Trial
Phase 2
Completed
Dec. 22, 2020
Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Trial
Phase 2
Completed
Dec. 22, 2020